Cardiac Drug, Digoxin, Could Lower Risk for Prostate Cancer, Johns Hopkins University Study

DNA India -- Scientists have found that heart drug, digoxin, could be a possible therapy for prostate cancer after using a combination of laboratory science and epidemiology. The scientists found that men using the cardiac drug had a 24 percent lower risk for prostate cancer, and said that further research may lead to use of the drug, or new ones that work the same way, to treat the cancer.

MORE ON THIS TOPIC